Blog

Nov 14, 2023

Empty capsules market size to increase by USD 1.10 billion from 2021 to 2026: ACG and Bright Pharma Caps Inc. among key vendors

NEW YORK, April 13, 2023 /PRNewswire/ -- The empty capsules market size is

NEW YORK, April 13, 2023 /PRNewswire/ -- The empty capsules market size is forecast to increase by USD 1.10 billion from 2021 to 2026, at a CAGR of 7.3%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing applications in the pharmaceutical industry, technological advances in empty capsules, and the growing geriatric population. Charts & data tables about market and segment sizes and analysis for the forecast period (2022-2026) have been covered in this report. Download the sample report

Vendor analysis: Vendor offerings

Technavio has extensively analyzed 15 major vendors, including ACG, Bright Pharma Caps Inc., Ajix Inc., Healthcaps India Ltd., Lonza Group Ltd., Mitsubishi Chemical Holdings Corp., Nectar Lifesciences Ltd., Qingdao Yiqing Biotechnology Co. Ltd., Roxlor LLC, Shanxi Guangsheng Medicinal Capsule Co. Ltd., Shanxi JC Biological Technology Co. Ltd., Snail Pharma Industry Co. Ltd., Suheung Co. Ltd., and Sunil Healthcare Ltd. The key offerings of some of these vendors are listed below:

ACG - The company offers HX vegetarian capsules that are suitable for pharmaceutical and nutraceutical applications. They are available in different color combinations of blue and white and can be used with titanium dioxide-free opacifiers.

Bright Pharma Caps Inc. - The company offers hydroxypropyl methylcellulose capsules produced with 100% plant-derived material. They are suitable for a wide range of formulations, including those that are liquid, hygroscopic, or otherwise sensitive to moisture.

Healthcaps India Ltd. - The company offers empty hard gelatin capsule shells, which are widely used in the encapsulation of drugs, vitamins, and antibiotics in powder and pellet forms by major pharmaceutical companies in India and abroad.

Lonza Group Ltd. - The company offers Coni Snap empty gelatin capsules, which are free from all synthetic excipients, such as SLS and mag stearate. These capsules fulfill the characteristics of nutritional ingredients and dietary preferences for consumers.

Mitsubishi Chemical Holdings Corp. - The company offer Quali GTM gelatin capsules, which are two-piece hard capsules for solid oral dosage forms. They are also used for dry powder inhalers, as well as for a broad line of pharmaceutical processing equipment.

Key benefits for industry players & stakeholders –

The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.

It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.

The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Expand operations in the future - To get requisite details and analysis, ask for a custom report.

Market Segmentation:

The market is segmented by type (gelatin capsules, and non-gelatin capsules) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

Based on type, the gelatin capsules segment will account for a significant share of the market growth during the forecast period. Gelatin capsules offer convenient packaging that ensures reliable dosing, portability, and high consumer compliance. As these capsules are soft, breakdown of the film and absorption of the drugs can be achieved without any side effects. Gelatin capsules are widely used in medications and dietary supplements. These factors will drive the growth of the gelatin capsules segment during the forecast period.

Get a holistic overview of the market from industry experts to evaluate and develop cost-effective growth strategies. Download the sample report

North America will account for 37% of the market's growth during the forecast period. The US is the key contributor to the empty capsules market in the region. Moreover, market growth in North America will be faster than the growth of the market in the Rest of the World (ROW). Factors such as the demand for US FDA-approved generic medicines will drive the market's growth in the region during the forecast period.

Market dynamics:

Key drivers:

Increasing applications in the pharmaceutical industry

Technological advancements in empty capsules

Growing geriatric population

The rise in the geriatric population and the demand for quick pharmaceutical services are driving the production of therapeutics. Factors such as rising healthcare awareness are increasing the sales of over-the-counter (OTC) drugs. OTC drug manufacturers are introducing medicines for treating minor ailments to cater to consumer requirements. This, in turn, increases the demand for empty capsules. Therefore, the rise in pharmaceutical sales is expected to augment the growth of the global market during the forecast period.

Major trends:

Increasing demand for generic drugs

New revenue pockets for empty capsules manufacturers

Increasing M&A

Generic drugs are substitutes for already marketed branded drugs. They have the same performance characteristics, clinical benefits, quality, dosage form, strength, safety, intended use, and route of administration as branded drugs. These drugs do not have to pass clinical trial or tests, which reduces their upfront research costs. In the past decade, generic drugs have saved USD 2.2 trillion dollars for the US healthcare system, according to the US FDA. Therefore, the increasing demand for generic drugs will support market growth during the forecast period.

Key challenges:

Risk of counterfeiting in pharmaceutical industry

Increasing prices of gelatin

Cultural practices and dietary restrictions

Counterfeit drugs can pose a threat to the lives of patients. They can also lead to financial losses for vendors of pharmaceuticals and packaging. This is because the after-effects of counterfeit drugs can harm the brand reputation of original manufacturers and lower consumer confidence. Moreover, the global pharmaceutical supply chain is complex, which increases the chance of an original product being stolen or replaced with counterfeit products. Thus, the risk of counterfeiting in the pharmaceutical industry can challenge the growth of the global market during the forecast period.

To get detailed insights about various market challenges and other data inclusions and exclusions, buy the report

What are the key data covered in this empty capsules market report?

CAGR of the market during the forecast period

Detailed information on factors that will drive the growth of the empty capsules market between 2022 and 2026

Precise estimation of the size of the empty capsules market and its contribution to the parent market

Accurate predictions about upcoming trends and changes in consumer behavior

Growth of the empty capsules market across North America, Europe, Asia, and Rest of World (ROW)

A thorough analysis of the market's competitive landscape and detailed information about vendors

Comprehensive analysis of factors that will challenge the growth of Empty Capsules Market vendors

Related Reports:

The global enteric empty capsules sales market size is estimated to grow by USD 55.74 million between 2021 to 2026, accelerating at a CAGR of 12.59%. This report extensively covers market segmentation by end-user (pharmaceutical, health supplements, and others) and geography (North America, Asia, Europe, and Rest of World (ROW)).

The smart pills drug delivery market size is expected to increase by USD 4.69 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 18.66%. The market is segmented by application (capsule endoscopy, drug delivery, and patient monitoring) and geography (North America, Europe, Asia, and Rest of World (ROW)

Gain instant access to 17,000+ market research reports having exclusive analysis and key parameters. Technavio's SUBSCRIPTION platform

Empty Capsules Market Scope

Report Coverage

Details

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.3%

Market growth 2022-2026

USD 1.10 billion

Market structure

Fragmented

YoY growth 2021-2022 (%)

6.7

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading vendors, market positioning of vendors, competitive strategies, and industry risks

Key companies profiled

ACG, Bright Pharma Caps Inc., Ajix Inc., Healthcaps India Ltd., Lonza Group Ltd., Mitsubishi Chemical Holdings Corp., Nectar Lifesciences Ltd., Qingdao Yiqing Biotechnology Co. Ltd., Roxlor LLC, Shanxi Guangsheng Medicinal Capsule Co. Ltd., Shanxi JC Biological Technology Co. Ltd., Snail Pharma Industry Co. Ltd., Suheung Co. Ltd., and Sunil Healthcare Ltd.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio Health Care market reports

Table of contents

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

4.1 Five forces summary

4.2 Bargaining power of buyers

4.3 Bargaining power of suppliers

4.4 Threat of new entrants

4.5 Threat of substitutes

4.6 Threat of rivalry

4.7 Market condition

5 Market Segmentation by Type

5.1 Market segments

5.2 Comparison by Type

5.3 Gelatin capsules - Market size and forecast 2021-2026

5.4 Non-Gelatin capsules - Market size and forecast 2021-2026

5.5 Market opportunity by Type

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

7.1 Geographic segmentation

7.2 Geographic comparison

7.3 North America - Market size and forecast 2021-2026

7.4 Europe - Market size and forecast 2021-2026

7.5 Asia - Market size and forecast 2021-2026

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

7.7 US - Market size and forecast 2021-2026

7.8 Germany - Market size and forecast 2021-2026

7.9 UK - Market size and forecast 2021-2026

7.10 China - Market size and forecast 2021-2026

7.11 Japan - Market size and forecast 2021-2026

7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

9.3 Landscape disruption

9.4 Industry risks

10 Vendor Analysis

10.1 Vendors covered

10.2 Market positioning of vendors

10.3 ACG

10.4 Ajix Inc.

10.5 Bright Pharma Caps Inc.

10.6 Healthcaps India Ltd.

10.7 Lonza Group Ltd.

10.8 Mitsubishi Chemical Holdings Corp.

10.9 Nectar Lifesciences Ltd.

10.10 Qingdao Yiqing Biotechnology Co. Ltd.

10.11 Shanxi Guangsheng Medicinal Capsule Co. Ltd.

10.12 Suheung Co. Ltd.

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

11.3 Currency conversion rates for US$

11.4 Research methodology

11.5 List of abbreviations

About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected]: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/empty-capsules-market-size-to-increase-by-usd-1-10-billion-from-2021-to-2026-acg-and-bright-pharma-caps-inc-among-key-vendors---technavio-301795642.html

SOURCE Technavio